Sangamo BioSciences | SGMO - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Alaunos Therapeutics USD 666K 304K 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 34.36B 598M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Cipla INR 250.61B 9.14B 2026-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 129.41M 7.88M 2026-06
CSL USD 11.85B 1000K 2025-12
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Grifols EUR 5.96B 316.31M 2025-12
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
J&J USD 56.35B 3.42B 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 45.01B 3.65B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 33.21B 1.68B 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Tectonic Therapeutic USD 231.1M 8.79M 2026-06
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09